Douglas Joseph Hirsch
CIK: 0001822522
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GoodRx Holdings, Inc.
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Oct 26, 2026GDRX
GoodRx Holdings, Inc.
Exercise(M)Direct20.5K shares- - Jun 16, 2026GDRX
GoodRx Holdings, Inc.
Award(A)Direct73.4K shares- - May 27, 2026GDRX
GoodRx Holdings, Inc.
Award(A)Direct4.6K shares- - Jan 1, 2026GDRX
GoodRx Holdings, Inc.
Award(A)Direct11K shares- - Oct 26, 2025GDRX
GoodRx Holdings, Inc.
Exercise(M)Direct20.5K shares- - Jun 3, 2025GDRX
GoodRx Holdings, Inc.
Award(A)Direct57.1K shares- - Jan 1, 2025GDRX
GoodRx Holdings, Inc.
Award(A)Direct6.4K shares- - Oct 26, 2024GDRX
GoodRx Holdings, Inc.
Award(A)Direct20.6K shares- - Oct 26, 2024GDRX
GoodRx Holdings, Inc.
Award(A)Direct797 shares- - Sep 1, 2024GDRX
GoodRx Holdings, Inc.
Conversion(C)Direct126.6K shares- - Sep 1, 2024GDRX
GoodRx Holdings, Inc.
Exercise(M)DirectRestricted Stock Unit
256.6K shares- - Sep 1, 2024GDRX
GoodRx Holdings, Inc.
Exercise(M)DirectClass B Common Stock
256.6K shares- - Sep 1, 2024GDRX
GoodRx Holdings, Inc.
Tax Payment(F)DirectClass B Common Stock
130K shares at avg. $7.90-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 26, 2026 | GDRX GoodRx Holdings, Inc. | Exercise(M) | 20,521 | - | $0 | Direct |
| Jun 16, 2026 | GDRX GoodRx Holdings, Inc. | Award(A) | 73,434 | - | $0 | Direct |
| May 27, 2026 | GDRX GoodRx Holdings, Inc. | Award(A) | 4,642 | - | $0 | Direct |
| Jan 1, 2026 | GDRX GoodRx Holdings, Inc. | Award(A) | 10,950 | - | $0 | Direct |
| Oct 26, 2025 | GDRX GoodRx Holdings, Inc. | Exercise(M) | 20,521 | - | - | Direct |
| Jun 3, 2025 | GDRX GoodRx Holdings, Inc. | Award(A) | 57,050 | - | - | Direct |
| Jan 1, 2025 | GDRX GoodRx Holdings, Inc. | Award(A) | 6,392 | - | $0 | Direct |
| Oct 26, 2024 | GDRX GoodRx Holdings, Inc. | Award(A) | 20,597 | - | $0 | Direct |
| Oct 26, 2024 | GDRX GoodRx Holdings, Inc. | Award(A) | 797 | - | $0 | Direct |
| Sep 1, 2024 | GDRX GoodRx Holdings, Inc. | Conversion(C) | 126,552 | - | $0 | Direct |
| Sep 1, 2024 | GDRX GoodRx Holdings, Inc. | Exercise(M) Restricted Stock Unit | 256,595 | - | - | Direct |
| Sep 1, 2024 | GDRX GoodRx Holdings, Inc. | Exercise(M) Class B Common Stock | 256,595 | - | - | Direct |
| Sep 1, 2024 | GDRX GoodRx Holdings, Inc. | Tax Payment(F) Class B Common Stock | 130,043 | $7.90 | - | Direct |
1-13 of 13 transactions
About Hirsch Douglas Joseph
Hirsch Douglas Joseph (SEC CIK 0001822522) files insider reports with the SEC as Director of GoodRx Holdings, Inc. (GDRX).
Signal8 holds 9 ownership filings by Hirsch Douglas Joseph, all Form 4s, filed between Sep 3, 2024 and Oct 26, 2026. Those filings report 13 transactions, from Sep 1, 2024 to Oct 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hirsch Douglas Joseph's filings is in SANTA MONICA, CA.
Recent filings by Hirsch Douglas Joseph
- Oct 26, 2026: Option exercise of GDRX shares (Form 4, code M).
- Jun 16, 2026: Grant or award of GDRX shares (Form 4, code A).
- May 27, 2026: Grant or award of GDRX shares (Form 4, code A).
- Jan 1, 2026: Grant or award of GDRX shares (Form 4, code A).
- Oct 26, 2025: Option exercise of GDRX shares (Form 4, code M).
Other insiders filing for GoodRx Holdings, Inc. (GDRX)
- Fengler Justin
- Chan Thomas (TC), Chief Accounting Officer
- Barnes Wendy Lynn
- FRANCISCO PARTNERS IV, L.P., 10% Owner
- McGinnis Christopher A
- REY-GIRAUD AGNES, Director